7/25/2019AstraZeneca Raises 2019 Sales Forecast on Strong Q2 China Performance ...

7/24/2019Outsourcing in China: How Far Can It Go?

7/24/2019NMPA Announces Withdrawal of 16 Certificate Requirements to Reduce Bur...

7/23/2019NHSA Seeks Comments on New Policy for Establishing Healthcare Security...

7/23/2019UCB Announces Approval of RA Drug Cimzia in China

7/23/2019WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspect...

7/22/2019Ascentage to Initiate Phase Ib Study of HQP1351 for Chronic Myeloid Le...

7/19/2019Recent Executive Moves

7/19/2019NHSA Publishes 2018 National Basic Medical Insurance Sector Developmen...

7/19/2019Novartis Wins Chinese Approval of MS Drug Gilenya

7/19/2019CDE Seeks Feedbacks on Implementation Suggestions for Transformation o...

7/19/2019Cross-sector Synergy: China Innovation at Merck

7/18/2019Alphamab Oncology Files IPO at HKEX

7/18/2019U.S. Targeting of Chinese Scientists Fuels a Brain Drain

7/18/2019State Council Issues Policy to Establish Inspection Forces for Drug Sa...

7/18/2019Snapshot of BMI System Financial Performance in Q2/2019

7/18/2019SMEI Releases Rankings of Top 100 Chinese Retail Pharmacy Chains in 20...

7/17/201960% of 135 Listed Biopharma Companies Issued Positive H1 Performance G...

7/17/2019China Daily: Latest Healthy China Guideline Targets Chronic Illnesses

7/16/2019SMEI President Reviews Pharma Industry Performance with Lowered Growth...

7/16/2019SMEI Releases Ranking of Top 100 Chinese Biopharma Companies in 2018

7/16/2019Chinese Biopharma Startups Raised $1,645M and Launched Seven IPOs in H...

7/16/2019Luye Pharma's Transdermal Patch Receives German Medical Regulatory App...

7/16/2019Trade War and China's Changing Trade Mark Law

7/15/2019State Council Issues the Action Plan for Healthy China Initiative

7/15/2019Central Government Urges to Enhanced Basic Medical Care for Impoverish...

7/15/2019SinoMab Files IPO in Hong Kong, Making It the First Homegrown Biotech ...

7/12/2019Recent Executive Moves

7/12/2019Takeda Files NDA for Entyvio (Vedolizumab) in China

7/12/2019Novartis Files NDA for Second Indication of Dabrafenib/Trametinib in C...

Page:136/357 Total number of articles:10697: [First][<<] [134] [135] [136] [137] [138] [>>] [End]